Literature DB >> 19360414

Effects of arginase inhibitors on the contractile and relaxant responses of isolated human penile erectile tissue.

Johan M Lorenzen1, Stefan Ückert, Friedemann Scheller, Hermann Haller, Markus A Kuczyk.   

Abstract

OBJECTIVES: An impairment in the local availability of nitric oxide (NO) may impair male erectile function. The activity of l-arginine-degrading arginase enzymes may attenuate the relaxation of cavernous smooth muscle by reducing local NO production. Arginase enzymes compete with the nitric oxide synthases for the common substrate, the amino acid l-arginine. Very little data are available regarding the significance of arginase enzymes in the control of human penile erectile tissue. The aim of the present study was to elucidate the effects of drugs known to inhibit arginase activity on the relaxation of isolated human corpus cavernosum (HCC) and the production of cyclic GMP.
METHODS: Using the organ bath technique, the effects of the arginase inhibitors DFMO, H-Orn-OH·HCl, H-lle-OH and nor-NOHA (10 nM–10 μM) on the tension induced by NE (1 μM) and the relaxation induced by electrical field stimulation (EFS) of HCC were investigated. HCC strips were also exposed to increasing concentrations of the compounds, and the production of cGMP was determined by means of a radioimmunoassay.
RESULTS: Only marginal effects of the arginase inhibitors were registered on the tension induced by NE and the relaxation exerted by EFS. Mean reversion of tension ranged from 18 to 8%. Only DFMO and nor-NOHA amplified the EFS-induced relaxation by 11 and 29%, respectively. These effects were not paralleled by an increase in tissue levels of cGMP.
CONCLUSION: Arginase inhibitors appeared to be ineffective in reversing the adrenergic tension and increasing the electrically induced relaxation of isolated HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360414     DOI: 10.1007/s00345-009-0405-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  12 in total

1.  Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction.

Authors:  T J Bivalacqua; W J Hellstrom; P J Kadowitz; H C Champion
Journal:  Biochem Biophys Res Commun       Date:  2001-05-18       Impact factor: 3.575

2.  Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor.

Authors:  R Baggio; F A Emig; D W Christianson; D E Ash; S Chakder; S Rattan
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

3.  Arginase-boronic acid complex highlights a physiological role in erectile function.

Authors:  J D Cox; N N Kim; A M Traish; D W Christianson
Journal:  Nat Struct Biol       Date:  1999-11

4.  Functional compartments in cyclic nucleotide action.

Authors:  J S Hayes; L L Brunton
Journal:  J Cyclic Nucleotide Res       Date:  1982

5.  Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum.

Authors:  N N Kim; J D Cox; R F Baggio; F A Emig; S K Mistry; S L Harper; D W Speicher; S M Morris; D E Ash; A Traish; D W Christianson
Journal:  Biochemistry       Date:  2001-03-06       Impact factor: 3.162

6.  In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue.

Authors:  Michael Seidler; Stefan Uckert; Eginhard Waldkirch; Christian G Stief; Matthias Oelke; Dimitrios Tsikas; Michael Sohn; Udo Jonas
Journal:  Eur Urol       Date:  2002-11       Impact factor: 20.096

7.  Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels.

Authors:  Dan E Berkowitz; Ron White; Dechun Li; Khalid M Minhas; Amy Cernetich; Soonyul Kim; Sean Burke; Artin A Shoukas; Daniel Nyhan; Hunter C Champion; Joshua M Hare
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

8.  Human arginase II: crystal structure and physiological role in male and female sexual arousal.

Authors:  Evis Cama; Diana M Colleluori; Frances A Emig; Hyunshun Shin; Soo Woong Kim; Noel N Kim; Abdulmaged M Traish; David E Ash; David W Christianson
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

Review 9.  Update on oral treatments for male erectile dysfunction.

Authors:  J S Kalsi; P D Kell
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-05       Impact factor: 6.166

Review 10.  The future of the oral pharmacotherapy of male erectile dysfunction: things to come.

Authors:  Stefan Uckert; Margit E Mayer; Christian G Stief; Udo Jonas
Journal:  Expert Opin Emerg Drugs       Date:  2007-05       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.